• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与配对的非癌症患者相比,癌症患者腰椎融合术的治疗结果

Lumbar Spinal Fusion Outcomes in Patients With Cancer Compared to Matched Peers Without Cancer.

作者信息

Gallagher Ryan S, Karsalia Ritesh, Xu Emily, Wathen Connor A, Borja Austin J, Na Jianbo, Collier Tara, McClintock Scott, Malhotra Neil R

机构信息

Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

McKenna EpiLog Fellowship in Population Health, at the University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Global Spine J. 2024 Dec 5:21925682241307631. doi: 10.1177/21925682241307631.

DOI:10.1177/21925682241307631
PMID:39639447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11622207/
Abstract

STUDY DESIGN

Retrospective Matched Cohort Study.

OBJECTIVES

Optimization of medical comorbidities is an essential part of preoperative management. However, the isolated effects of individual comorbidities have not been evaluated within a homogenous spine surgery population. This exact matching study aims to assess the independent effects of cancer on outcomes following single-level lumbar fusions for non-cancer surgery.

METHODS

4680 consecutive patients undergoing single-level posterior-only lumbar fusion were retrospectively enrolled. Univariate statistics and coarsened exact matching (CEM) were computed to evaluate outcomes between cancer patients and those without comorbidities.

RESULTS

By logistic regression, malignancy conferred a higher risk of surgical complication ( = 0.016, OR = 2.64, CI = [1.200,5.790]), 30- and 90- day readmission ( = 0.012, OR = 2.025, CI = [1.170-3.510]; < 0.001, OR = 2.34, CI = [1.430, 3.830], respectively), 90-day reoperation ( < 0.001, OR = 2.16, [1.110, 4.200]), and death at 90-days ( = 0.032, OR = 8.27, CI = [1.200, 56.850]). After matching, malignancy was associated with increased odds of incidental durotomy (6 vs 0 cases, = 0.048) and death at both 30 and 90 days (both: OR = 8.0, = 0.020, CI = [1.00, 63.960]). No cases of durotomy occurred in cases with mortality in the matched sample, suggesting independent relationships. There were no differences in length of stay, non-home discharge, ED evaluation, readmission, or reoperations.

CONCLUSION

Among otherwise exact-matched patients undergoing single level lumbar fusion, history of malignancy conferred a higher risk of short-term mortality, but not other outcomes suggestive of surgical failure. Increased mortality after lumbar fusion should be studied further and may play a role in surgical decision-making and patient discussions.

摘要

研究设计

回顾性匹配队列研究。

目的

优化合并症是术前管理的重要组成部分。然而,在同质化的脊柱手术人群中,尚未评估个体合并症的单独影响。这项精确匹配研究旨在评估癌症对非癌症手术单节段腰椎融合术后结局的独立影响。

方法

回顾性纳入4680例连续接受单节段后路腰椎融合术的患者。计算单因素统计量和粗化精确匹配(CEM),以评估癌症患者与无合并症患者之间的结局。

结果

通过逻辑回归分析,恶性肿瘤导致手术并发症风险更高(P = 0.016,OR = 2.64,CI = [1.200, 5.790])、30天和90天再入院风险更高(P = 0.012,OR = 2.025,CI = [1.170 - 3.510];P < 0.001,OR = 2.34,CI = [1.430, 3.830])、90天再次手术风险更高(P < 0.001,OR = 2.16,[1.110, 4.200])以及90天死亡风险更高(P = 0.032,OR = 8.27,CI = [1.200, 56.850])。匹配后,恶性肿瘤与意外硬脊膜切开术几率增加(6例对0例,P = 0.048)以及30天和90天死亡几率增加相关(两者:OR = 8.0,P = 0.020,CI = [1.00, 63.960])。在匹配样本中,死亡病例未发生硬脊膜切开术,提示存在独立关系。住院时间、非回家出院、急诊评估、再入院或再次手术方面无差异。

结论

在其他方面精确匹配的接受单节段腰椎融合术的患者中,恶性肿瘤病史导致短期死亡风险更高,但不导致其他提示手术失败的结局风险增加。腰椎融合术后死亡率增加应进一步研究,可能在手术决策和患者讨论中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/7d9644f18494/10.1177_21925682241307631-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/bf11ceb38c4e/10.1177_21925682241307631-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/a62c2925e389/10.1177_21925682241307631-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/7d9644f18494/10.1177_21925682241307631-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/bf11ceb38c4e/10.1177_21925682241307631-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/a62c2925e389/10.1177_21925682241307631-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/12127690/7d9644f18494/10.1177_21925682241307631-fig3.jpg

相似文献

1
Lumbar Spinal Fusion Outcomes in Patients With Cancer Compared to Matched Peers Without Cancer.与配对的非癌症患者相比,癌症患者腰椎融合术的治疗结果
Global Spine J. 2024 Dec 5:21925682241307631. doi: 10.1177/21925682241307631.
2
Relationship Between Comorbidity Burden and Short-Term Outcomes Across 4680 Consecutive Spinal Fusions.4680 例连续脊柱融合术后共病负担与短期结局的关系。
World Neurosurg. 2023 Dec;180:e84-e90. doi: 10.1016/j.wneu.2023.08.044. Epub 2023 Aug 18.
3
The effect of chronic kidney disease on short-term single-level lumbar fusion outcomes.慢性肾脏病对单节段腰椎融合短期疗效的影响。
Clin Neurol Neurosurg. 2024 Sep;244:108459. doi: 10.1016/j.clineuro.2024.108459. Epub 2024 Jul 15.
4
Diabetes and heart disease do not affect short-term lumbar fusion outcomes accounting for other risk factors in a matched cohort analysis.在一项匹配队列分析中,考虑到其他风险因素,糖尿病和心脏病并不影响短期腰椎融合手术的结果。
World Neurosurg X. 2024 Sep 23;24:100410. doi: 10.1016/j.wnsx.2024.100410. eCollection 2024 Oct.
5
Disparities Attributable to Sex Differences in 4680 Lumbar Fusion Outcomes.4680例腰椎融合手术结果中性别差异导致的差距
World Neurosurg. 2025 Feb;194:123586. doi: 10.1016/j.wneu.2024.123586. Epub 2025 Jan 16.
6
Low Household Income Increases Hospital Length of Stay and Decreases Home Discharge Rates in Lumbar Fusion.家庭收入低会增加腰椎融合手术患者的住院时间并降低出院回家的比例。
Global Spine J. 2025 Mar;15(2):1330-1337. doi: 10.1177/21925682241239609. Epub 2024 Mar 21.
7
Patients undergoing overlapping posterior single-level lumbar fusion are not at greater risk for adverse 90-day outcomes.接受重叠后路单节段腰椎融合术的患者,其 90 天内不良结局的风险并不更高。
Clin Neurol Neurosurg. 2021 Apr;203:106584. doi: 10.1016/j.clineuro.2021.106584. Epub 2021 Mar 2.
8
Overlapping single-level lumbar fusion and adverse short-term outcomes.重叠单节段腰椎融合术与不良短期预后
J Neurosurg Spine. 2021 Aug 6;35(5):571-582. doi: 10.3171/2020.12.SPINE201861. Print 2021 Nov 1.
9
Matched Analysis of the Risk Assessment and Prediction Tool for Discharge Planning Following Single-Level Posterior Lumbar Fusion.单节段后路腰椎融合术后出院计划风险评估和预测工具的配对分析。
World Neurosurg. 2022 Jul;163:e113-e123. doi: 10.1016/j.wneu.2022.03.069. Epub 2022 Mar 18.
10
Revision lumbar fusions have higher rates of reoperation and result in worse clinical outcomes compared to primary lumbar fusions.与初次腰椎融合术相比,翻修腰椎融合术的再次手术率更高,临床结果更差。
Spine J. 2023 Jan;23(1):105-115. doi: 10.1016/j.spinee.2022.08.018. Epub 2022 Sep 2.

本文引用的文献

1
Chemotherapy-Mediated Complications of Wound Healing: An Understudied Side Effect.化疗导致的伤口愈合并发症:一个被低估的副作用。
Adv Wound Care (New Rochelle). 2024 Apr;13(4):187-199. doi: 10.1089/wound.2023.0097. Epub 2024 Feb 14.
2
Anterolateral versus posterior minimally invasive lumbar interbody fusion surgery for spondylolisthesis: comparison of outcomes from a global, multicenter study at 12-months follow-up.后路与前路微创腰椎间融合术治疗腰椎滑脱症:12 个月随访的全球多中心研究结果比较。
Spine J. 2023 Oct;23(10):1494-1505. doi: 10.1016/j.spinee.2023.05.013. Epub 2023 May 25.
3
Bodywide ecological interventions on cancer.
全身性生态干预癌症。
Nat Med. 2023 Jan;29(1):59-74. doi: 10.1038/s41591-022-02193-4. Epub 2023 Jan 19.
4
Single-Position Oblique Lumbar Interbody Fusion and Percutaneous Pedicle Screw Fixation under O-Arm Navigation: A Retrospective Comparative Study.O型臂导航下单节段斜外侧腰椎椎间融合术与经皮椎弓根螺钉内固定术:一项回顾性对比研究
J Clin Med. 2022 Dec 30;12(1):312. doi: 10.3390/jcm12010312.
5
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.归因于风险因素的癌症全球负担,2010-19 年:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Aug 20;400(10352):563-591. doi: 10.1016/S0140-6736(22)01438-6.
6
Cancer-associated venous thromboembolism.癌症相关静脉血栓栓塞症。
Nat Rev Dis Primers. 2022 Feb 17;8(1):11. doi: 10.1038/s41572-022-00336-y.
7
Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency.癌症治疗相关肾上腺功能不全的风险评估、诊断及治疗
Expert Rev Endocrinol Metab. 2022 Jan;17(1):21-33. doi: 10.1080/17446651.2022.2023009. Epub 2022 Jan 3.
8
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.2010 年至 2019 年 29 种癌症的发病率、死亡率、生命损失年数、失能生存年数和伤残调整生命年:2019 年全球疾病负担研究的系统分析。
JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.
9
Postoperative outcomes and the association with overlap before or after the critical step of lumbar fusion.腰椎融合关键步骤前后的术后结果及其与重叠的关联。
J Neurosurg Spine. 2021 Oct 1;36(3):366-375. doi: 10.3171/2021.5.SPINE202105. Print 2022 Mar 1.
10
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward.癌症患者的抗生素耐药性:不断升级的挑战和前进道路。
CA Cancer J Clin. 2021 Nov;71(6):488-504. doi: 10.3322/caac.21697. Epub 2021 Sep 21.